He explains the rationale for combining GLP-1 and glucagon for MASH, and discusses 24-week data that was released earlier this year. 48-week data will be coming in the fourth quarter, as well as a meeting with FDA.
Coverage brought to you by:
Also look for unique social pages for BiotechTV U.
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.
Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.
.png){kind=logo}